Clinical and molecular studies of EXT1/EXT2 in Bulgaria

J Inherit Metab Dis. 2011 Aug;34(4):917-21. doi: 10.1007/s10545-011-9314-8. Epub 2011 Apr 16.

Abstract

EXT1/EXT2-CDG (Multiple cartilagineous exostoses, hereditary multiple osteochondroma (MO); OMIM 133700/133701) are common defects of O-xylosylglycan glycosylation. The diagnostic criteria are at least two osteochondromas of the juxta-epiphyseal region of long bones with in the majority of cases a positive family history and/or mutation in one of the EXT genes. The authors report data on clinical symptoms and complications of 23 patients (from 16 families), discussing the family history, age of diagnosis, new clinical and molecular data. Fifteen mutations and large deletions, of which nine are new, were detected in the EXT1 and EXT2 gene by sequence analysis, FISH and MLPA analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Bulgaria
  • Child
  • Child, Preschool
  • Congenital Disorders of Glycosylation / complications
  • Congenital Disorders of Glycosylation / genetics
  • DNA Mutational Analysis / methods
  • Exostoses, Multiple Hereditary / complications
  • Exostoses, Multiple Hereditary / diagnosis
  • Exostoses, Multiple Hereditary / genetics*
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Middle Aged
  • N-Acetylglucosaminyltransferases / genetics*
  • N-Acetylglucosaminyltransferases / physiology
  • Young Adult

Substances

  • N-Acetylglucosaminyltransferases
  • exostosin-1
  • exostosin-2